Cargando…

At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue

Detalles Bibliográficos
Autores principales:	Austelle, Christopher, Badran, Bashar, Huffman, Sarah, Dancy, Morgan, Kautz, Steven, George, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598229/ http://dx.doi.org/10.1016/j.brs.2021.10.368

Ejemplares similares

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
por: Huffman, Sarah, et al.
Publicado: (2021)

A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
por: Badran, Bashar W., et al.
Publicado: (2022)

A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
por: Badran, Bashar W, et al.
Publicado: (2022)

Electroencephalographic Patterns in taVNS: A Systematic Review
por: Gianlorenco, Anna Carolyna L., et al.
Publicado: (2022)

Remotely supervised at-home delivery of taVNS for autism spectrum disorder: feasibility and initial efficacy
por: Black, Benjamin, et al.
Publicado: (2023)

Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis
por: Kim, Angela Yun, et al.
Publicado: (2022)

No modulation of pupil size and event-related pupil response by transcutaneous auricular vagus nerve stimulation (taVNS)
por: Keute, Marius, et al.
Publicado: (2019)

Transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of pediatric nephrotic syndrome: a pilot study
por: Merchant, Kumail, et al.
Publicado: (2022)

439 The effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on hypoxic-ischemic injury in newborn rats
por: Wiley, Melanie Gail, et al.
Publicado: (2022)

Transcranial Auricular Vagus Nerve Stimulation (taVNS) and Ear-EEG: Potential for Closed-Loop Portable Non-invasive Brain Stimulation
por: Ruhnau, Philipp, et al.
Publicado: (2021)

The Effect of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on P3 Event-Related Potentials during a Bayesian Oddball Task
por: Warren, Claire V., et al.
Publicado: (2020)

Transcutaneous auricular vagus nerve stimulation induces stabilizing modifications in large-scale functional brain networks: towards understanding the effects of taVNS in subjects with epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

An assessor-blinded, randomized comparative trial of transcutaneous auricular vagus nerve stimulation (taVNS) combined with cranial electroacupuncture vs. citalopram for depression with chronic pain
por: Li, Shaoyuan, et al.
Publicado: (2022)

Expiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) does not Further Augment Heart Rate Variability During Slow Breathing at 0.1 Hz
por: Szulczewski, Mikołaj Tytus, et al.
Publicado: (2023)

A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders
por: Thompson, Sean L., et al.
Publicado: (2021)

Synchronized cervical VNS with accelerated theta burst TMS for treatment resistant depression
por: George, Mark S., et al.
Publicado: (2020)

Model Phrases for VNs
por: Department, HR
Publicado: (2011)

PPAR-γ Mediates Ta-VNS-Induced Angiogenesis and Subsequent Functional Recovery after Experimental Stroke in Rats
por: Li, Jiani, et al.
Publicado: (2020)

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
por: Chiquette, Elaine, et al.
Publicado: (2012)

Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly
por: Shaw, Jonathan E., et al.
Publicado: (2017)

Twice or Thrice Weekly versus Daily Thyroxine in Hypothyroid Fasting Ramadan: A Pilot Study
por: Elsherbiny, Tamer Mohamed
Publicado: (2022)

Is Twice-weekly Maintenance Hemodialysis Justified?
por: Mendonca, Satish, et al.
Publicado: (2021)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
por: Sugimoto, T., et al.
Publicado: (2019)

Effects of repetitive twice-weekly transcranial direct current stimulations on fatigue and fatigability in people with multiple sclerosis
por: Linnhoff, Stefanie, et al.
Publicado: (2023)

Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily1
por: Best, J H, et al.
Publicado: (2009)

Twice‐Daily Doravirine Overcomes the Interaction Effect from Once‐Weekly Rifapentine and Isoniazid in Healthy Volunteers
por: Lam, Edwin, et al.
Publicado: (2020)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
por: Sugimoto, Toshitsugu, et al.
Publicado: (2021)

Practical guide to choosing dabigatran 150 mg twice daily or apixaban 5 mg twice daily for patients with atrial fibrillation
por: Kobayashi, Zen, et al.
Publicado: (2019)

Vagus Nerve Stimulator (VNS)-induced Severe Obstructive Sleep Apnea Which Resolved After the VNS Was Turned Off
por: Gurung, Puja, et al.
Publicado: (2020)

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
por: Kumar, Princy N, et al.
Publicado: (2009)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Feasibility of Twice-Weekly Hemodialysis During COVID-19
por: Siga, Esteban
Publicado: (2021)

Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease
por: Sakai, Yukinao, et al.
Publicado: (2013)

Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes
por: Wysham, Carol H., et al.
Publicado: (2017)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012)

Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD
por: Fisher, Kristy A., et al.
Publicado: (2022)

A Comparison of Practice Pattern and Outcome of Twice-weekly and Thrice-weekly Hemodialysis Patients
por: Mukherjee, T., et al.
Publicado: (2017)

Incremental and Once- to Twice-Weekly Hemodialysis: From Experience to Evidence
por: Obi, Yoshitsugu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_frko6s6q3cnf9j2jc2pvojrb5a